Lipoflex Peri (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

The solution delivers a balanced blend of essential and non‑essential amino acids directly into the bloodstream. These amino acids become substrates for protein synthesis, help restore nitrogen balance, and support anabolic processes, tissue repair, and immune function in patients who rely on parenteral nutrition.

The prescribed dose of Lipoflex Peri is individualized by the treating physician based on the patient’s weight, metabolic needs, renal and hepatic function, and overall nutritional goals. Dosage calculations follow established parenteral nutrition protocols and are adjusted according to laboratory monitoring.

Safety data for Lipoflex Peri in pregnancy and lactation are limited. Because it is a parenteral nutrition product, it should only be used when the potential benefits to the mother outweigh any possible risks to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain logistics if needed—and necessary import documentation.

Compared with generic amino acid solutions, Lipoflex Peri offers a comprehensive profile of essential amino acids formulated to EU standards. It is designed for compatibility with standard parenteral nutrition regimens and provides consistent sterility and stability. Clinicians may select it based on formulation preferences, regulatory compliance, and supplier reliability rather than a distinct pharmacologic advantage.

Lipoflex Peri must be stored refrigerated at 2‑8 °C, protected from light, and kept in its original container to maintain sterility. The product should not be frozen or shaken vigorously. Before administration, allow the solution to reach room temperature if required, and inspect for particulate matter or discoloration.

The solution is administered intravenously, typically via a peripheral or central venous catheter, as part of a prescribed parenteral nutrition regimen. Infusion rates are calculated by the clinical team based on the patient’s nutritional prescription and are delivered using an infusion pump or controlled drip set to ensure accurate dosing.

Serious adverse events, although rare, can include metabolic acidosis, severe allergic reactions such as anaphylaxis, hyperosmolarity leading to fluid overload, and renal impairment in susceptible individuals. Prompt recognition and management of these reactions are essential, and patients should be monitored closely during and after infusion.

Lipoflex Peri is contraindicated in patients with known hypersensitivity to any of its amino acid components or to the solution’s excipients. It should also be avoided in individuals with uncontrolled hyperammonemia, severe metabolic disorders affecting amino acid metabolism, or in cases where parenteral nutrition is not indicated. Clinical judgment is required to assess suitability.